These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 11912253)
1. Effects of mycophenolate mofetil in mercury-induced autoimmune nephritis. Nieto E; Escudero E; Navarro E; Yáñez-Mo M; Martín A; Pérez de Lema G; Sánchez-Madrid F; Mampaso F J Am Soc Nephrol; 2002 Apr; 13(4):937-945. PubMed ID: 11912253 [TBL] [Abstract][Full Text] [Related]
2. Prevention of mercuric chloride-induced nephritis in the brown Norway rat by treatment with antibodies against the alpha 4 integrin. Molina A; Sánchez-Madrid F; Bricio T; Martín A; Barat A; Alvarez V; Mampaso F J Immunol; 1994 Sep; 153(5):2313-20. PubMed ID: 8051427 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of all-trans-retinoic acid (at-RA) on an autoimmune nephritis experimental model: role of the VLA-4 integrin. Escribese MM; Conde E; Martín A; Sáenz-Morales D; Sancho D; Pérez de Lema G; Lucio-Cazaña J; Sánchez-Madrid F; García-Bermejo ML; Mampaso FM BMC Nephrol; 2007 Jan; 8():3. PubMed ID: 17250768 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of antibodies to vascular cell adhesion molecule-1 and distinct epitopes of the alpha4 integrin in HgCl2-induced nephritis in Brown Norway rats. Escudero E; Nieto M; Martín A; Molina A; Lobb RR; Sanchez-Madrid F; Mampaso F J Am Soc Nephrol; 1998 Oct; 9(10):1881-91. PubMed ID: 9773789 [TBL] [Abstract][Full Text] [Related]
5. Functional relevance of activated beta1 integrins in mercury-induced nephritis. Escudero E; Martín A; Nieto M; Nieto E; Navarro E; Luque A; Cabañas C; Sánchez-Madrid F; Mampaso F J Am Soc Nephrol; 2000 Jun; 11(6):1075-1084. PubMed ID: 10820171 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil. Blaheta RA; Leckel K; Wittig B; Zenker D; Oppermann E; Harder S; Scholz M; Weber S; Schuldes H; Encke A; Markus BH Transpl Immunol; 1998 Dec; 6(4):251-9. PubMed ID: 10342739 [TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease. Corna D; Morigi M; Facchinetti D; Bertani T; Zoja C; Remuzzi G Kidney Int; 1997 May; 51(5):1583-9. PubMed ID: 9150476 [TBL] [Abstract][Full Text] [Related]
8. Mercury-induced autoimmune glomerulonephritis in inbred rats. I. Kinetics and species specificity of autoimmune responses. Michaelson JH; McCoy JP; Hirszel P; Bigazzi PE Surv Synth Pathol Res; 1985; 4(5-6):401-11. PubMed ID: 3837930 [TBL] [Abstract][Full Text] [Related]
9. Treatment with mycophenolate mofetil attenuates the development of Heymann nephritis. Luca ME; Paul LC; van Der Wal AM; Bruijn JA; de Heer E Exp Nephrol; 2000; 8(2):77-83. PubMed ID: 10729746 [TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition. Penny MJ; Boyd RA; Hall BM J Am Soc Nephrol; 1998 Dec; 9(12):2272-82. PubMed ID: 9848781 [TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil prevents development of urinary protein in autoimmune nephritis. Takeda S; Takahashi M; Kusano E; Kobayashi E Kidney Int; 2003 Jul; 64(1):365-6; author reply 366. PubMed ID: 12787433 [No Abstract] [Full Text] [Related]
12. Mycophenolate mofetil prevents autoimmune glomerulonephritis and alterations of intrarenal adrenomedullin in rats. Shi Y; Yoshihara F; Nakahama H; Goto R; Sada M; Kawano Y; Moriyama T; Yazawa K; Ichimaru N; Takahara S; Kangawa K Eur J Pharmacol; 2004 Apr; 489(1-2):127-33. PubMed ID: 15063164 [TBL] [Abstract][Full Text] [Related]
13. Autoregulation of autoantibody synthesis in mercuric chloride nephritis in the Brown Norway rat. I. A role for T suppressor cells. Bowman C; Mason DW; Pusey CD; Lockwood CM Eur J Immunol; 1984 May; 14(5):464-70. PubMed ID: 6233159 [TBL] [Abstract][Full Text] [Related]
15. Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats. Takeda S; Takahashi M; Sado Y; Takeuchi K; Hakamata Y; Shimizu H; Kaneko T; Yamamoto H; Ito C; Ookawara S; Asano Y; Kusano E; Kobayashi E Nephrol Dial Transplant; 2004 Sep; 19(9):2228-36. PubMed ID: 15238626 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of murine lupus nephritis by mycophenolate mofetil. Van Bruggen MC; Walgreen B; Rijke TP; Berden JH J Am Soc Nephrol; 1998 Aug; 9(8):1407-15. PubMed ID: 9697662 [TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. Hu W; Liu Z; Chen H; Tang Z; Wang Q; Shen K; Li L Chin Med J (Engl); 2002 May; 115(5):705-9. PubMed ID: 12133539 [TBL] [Abstract][Full Text] [Related]
18. Distinct effects of mycophenolate mofetil and cyclophosphamide on renal fibrosis in NZBWF1/J mice. Yung S; Zhang Q; Chau MK; Chan TM Autoimmunity; 2015; 48(7):471-87. PubMed ID: 26099989 [TBL] [Abstract][Full Text] [Related]
19. Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis. Ziswiler R; Steinmann-Niggli K; Kappeler A; Daniel C; Marti HP J Am Soc Nephrol; 1998 Nov; 9(11):2055-66. PubMed ID: 9808091 [TBL] [Abstract][Full Text] [Related]
20. Effects of mycophenolic acid mofetil on acute rejection of kidney allografts in rats. Heemann U; Azuma H; Schmid C; Philipp T; Tilney N Clin Nephrol; 1996 May; 45(5):355-7. PubMed ID: 8738672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]